Medical Mondays | Cannabis Therapeutics and the Future of Neurology

By Ethan B. Russo | 18th Octobre 2018 Neurological therapeutics have been hampered by its inability to advance beyond symptomatic treatment of neurodegenerative disorders into the realm of actual palliation, arrest or reversal of the attendant pathological processes. While cannabis-based medicines have demonstrated safety, efficacy and consistency sufficient for regulatory approval in spasticity in multiple sclerosis (MS), and in Dravet and Lennox-Gastaut
Read more
You must be logged in to post a comment.